Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.
Viral vectors can enable innovative medical treatments, but only with a comprehensive formulation development plan
The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards
Viral vector manufacture has come a long way, but the story is far from over.
In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.
What will drug development look like aboard a new commercial space station?
Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.
How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.
What are the key decisions that need to be made for cell therapy supply chains?
The Medicine Maker’s round up of the top news stories in the pharma industry in March.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
The Human Cost of Poor Practice
Getting Started With Digitization
Positive Opinion for Regeneron’s Libtayo